Serum pseudocholinesterase: high density lipoprotein cholesterol ratio as an index of risk for cardiovascular disease.
A significant increase in the ratio of serum pseudocholinesterase/high density lipoprotein cholesterol (the Complementary Risk Factor ratio) was found in individuals classified as high risk for cardiovascular disease on the basis of the ratio of total cholesterol/high density lipoprotein cholesterol (the Established Risk Factor ratio) compared to the individuals with average and low risks. This Complementary Risk Factor ratio also showed good correlation with serum low density lipoprotein, triglycerides and the Established Risk Factor ratio. These results indicate that serum cholinesterase has a parallel relationship with low density lipoproteins and a reciprocal relationship with high density lipoproteins. We propose that the Complementary Risk Factor ratio may be an additional marker in predicting the risks for cardiovascular disease.
D002091:Butyrylcholinesterase / Q000097:blood*; D002318:Cardiovascular Diseases / Q000097:blood*; D002802:Cholinesterases / Q000097:blood*; D004796:Clinical Enzyme Tests; D019411:Clinical Laboratory Techniques; D006801:Humans; D008075:Lipoproteins, HDL / Q000097:blood*; D012044:Regression Analysis; D012306:Risk
D008075:Lipoproteins, HDL; D002091:Butyrylcholinesterase; D002802:Cholinesterases